Microport Cardioflow Medtech Corp
HKEX:2160
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Microport Cardioflow Medtech Corp
Other Current Liabilities
Microport Cardioflow Medtech Corp
Other Current Liabilities Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Other Current Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Microport Cardioflow Medtech Corp
HKEX:2160
|
Other Current Liabilities
¥302.1m
|
CAGR 3-Years
209%
|
CAGR 5-Years
-26%
|
CAGR 10-Years
N/A
|
|
|
A
|
APT Medical Inc
SSE:688617
|
Other Current Liabilities
¥171.1m
|
CAGR 3-Years
-9%
|
CAGR 5-Years
35%
|
CAGR 10-Years
N/A
|
|
|
J
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SZSE:002223
|
Other Current Liabilities
¥651.1m
|
CAGR 3-Years
13%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
16%
|
|
|
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
|
Other Current Liabilities
¥5.5B
|
CAGR 3-Years
-6%
|
CAGR 5-Years
4%
|
CAGR 10-Years
N/A
|
|
|
Andon Health Co Ltd
SZSE:002432
|
Other Current Liabilities
¥149.7m
|
CAGR 3-Years
-50%
|
CAGR 5-Years
22%
|
CAGR 10-Years
14%
|
|
|
Shanghai United Imaging Healthcare Co Ltd
SSE:688271
|
Other Current Liabilities
¥2.9B
|
CAGR 3-Years
3%
|
CAGR 5-Years
15%
|
CAGR 10-Years
N/A
|
|
Microport Cardioflow Medtech Corp
Glance View
MicroPort CardioFlow Medtech Corp. operates as a holding company with interest in developing medical devices. The company is headquartered in Shanghai, Shanghai. The company went IPO on 2021-02-04. The firm is mainly engaged in the development and commercialization of transcatheter and surgical solutions for valvular heart diseases. The firm's main products include the first-generation transcatheter aortic heart valve implantation (TAVI) product VitaFlow and the second-generation TAVI product VitaFlow II. The firm mainly conducts business within the domestic market.
See Also
What is Microport Cardioflow Medtech Corp's Other Current Liabilities?
Other Current Liabilities
302.1m
CNY
Based on the financial report for Dec 31, 2025, Microport Cardioflow Medtech Corp's Other Current Liabilities amounts to 302.1m CNY.
What is Microport Cardioflow Medtech Corp's Other Current Liabilities growth rate?
Other Current Liabilities CAGR 5Y
-26%
Over the last year, the Other Current Liabilities growth was 0%. The average annual Other Current Liabilities growth rates for Microport Cardioflow Medtech Corp have been 209% over the past three years , -26% over the past five years .
